Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
9.86
+0.07 (0.72%)
Nov 21, 2024, 1:23 PM EST - Market open

Neumora Therapeutics Statistics

Total Valuation

NMRA has a market cap or net worth of $1.59 billion. The enterprise value is $1.24 billion.

Market Cap 1.59B
Enterprise Value 1.24B

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date Nov 12, 2024
Ex-Dividend Date n/a

Share Statistics

NMRA has 161.56 million shares outstanding. The number of shares has increased by 368.32% in one year.

Current Share Class 161.56M
Shares Outstanding 161.56M
Shares Change (YoY) +368.32%
Shares Change (QoQ) +0.37%
Owned by Insiders (%) 5.78%
Owned by Institutions (%) 47.66%
Float 84.92M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 4.90
P/TBV Ratio 4.93
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.98, with a Debt / Equity ratio of 0.01.

Current Ratio 10.98
Quick Ratio 10.75
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -70.48% and return on invested capital (ROIC) is -37.20%.

Return on Equity (ROE) -70.48%
Return on Assets (ROA) -34.92%
Return on Capital (ROIC) -37.20%
Revenue Per Employee n/a
Profits Per Employee -$2.37M
Employee Count 124
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, NMRA has paid $446,000 in taxes.

Income Tax 446,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -16.62% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -16.62%
50-Day Moving Average 12.97
200-Day Moving Average 12.40
Relative Strength Index (RSI) 35.53
Average Volume (20 Days) 1,143,379

Short Selling Information

The latest short interest is 9.37 million, so 5.80% of the outstanding shares have been sold short.

Short Interest 9.37M
Short Previous Month 9.01M
Short % of Shares Out 5.80%
Short % of Float 11.03%
Short Ratio (days to cover) 7.45

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -250.64M
Pretax Income -273.79M
Net Income -293.70M
EBITDA -250.00M
EBIT -250.64M
Earnings Per Share (EPS) -$1.86
Full Income Statement

Balance Sheet

The company has $341.31 million in cash and $2.75 million in debt, giving a net cash position of $338.56 million or $2.10 per share.

Cash & Cash Equivalents 341.31M
Total Debt 2.75M
Net Cash 338.56M
Net Cash Per Share $2.10
Equity (Book Value) 320.74M
Book Value Per Share 2.00
Working Capital 316.87M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$184.04 million and capital expenditures -$819,000, giving a free cash flow of -$184.86 million.

Operating Cash Flow -184.04M
Capital Expenditures -819,000
Free Cash Flow -184.86M
FCF Per Share -$1.14
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NMRA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -368.32%
Shareholder Yield -368.32%
Earnings Yield -18.57%
FCF Yield -11.69%

Analyst Forecast

The average price target for NMRA is $23.40, which is 137.32% higher than the current price. The consensus rating is "Strong Buy".

Price Target $23.40
Price Target Difference 137.32%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -34.77%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1